The healthcare industry is in the midst of a seismic transformation. The days of a one-size-fits-all, relationship-based sales model are fading, replaced by a complex, data-rich ecosystem.
The drivers are clear: the rise of patient consumerism, the rapid shift to value-based care, and the explosion of digital health platforms have fundamentally altered how medical devices, pharmaceuticals, and health-tech services are sold and adopted.
“Addressing the challenges facing healthcare organizations today requires substantive business transformation,” Tom Kiesau, Chartis’ Chief AI & Digital Officer and co-author of the Chartis Digital Transformation Survey, said.
He added that digitally transforming your organization plays a critical role, and the changes necessary start at the top of the organization as a strategic imperative and must be embraced all the way down the line.
“We may finally be at a tipping point if 90% of healthcare executives agree on the need for fundamental change,” Tom said. “Organizations need to capitalize on the momentum in this moment—and ensure that they are truly realizing the potential presented by AI and digital capabilities to drive needed business transformation at scale.”
For go-to-market (GTM) leaders, this new landscape presents a critical challenge. The traditional playbook—built on geographic territories and high-touch, in-person meetings—is no longer sufficient. It’s slow, inefficient, and ill-equipped to navigate a market where purchasing decisions are made by diverse committees and influenced by an avalanche of clinical and operational data.
The volume of healthcare data alone is projected to grow at a compound annual rate of 36%, far outpacing industries like manufacturing and finance since 2025.
The diagnosis is clear: The traditional healthcare GTM model is suffering from operational friction. The prescription? A powerful combination of Artificial Intelligence (AI) and a robust Revenue Operations (RevOps) framework.
The Symbiotic Solution: AI as the Brain, RevOps as the Central Nervous System
Many organizations are turning to AI to make sense of this data. The global AI in healthcare market is expected to skyrocket from $20.9 billion in 2023 to over $200 billion by 2030, a clear signal of its perceived value.
AI is brilliant at identifying patterns and generating insights. It can predict which providers are most likely to convert, identify patient populations, and flag accounts with the highest growth potential.
But insight without action is just expensive data science. This is where Revenue Operations provides the missing link.
- AI is the intelligence engine. It analyzes the “what” and “why.”
- RevOps is the operational backbone. It builds the “how”—the processes, systems, and GTM structure to execute on those insights at scale.
AI can tell you the ideal customer profile has shifted. A strong RevOps function, which top-performing companies are 75% more likely to have by the end of 2026, allows you to instantly model and deploy a new territory plan, re-route opportunities, and adjust quotas to capitalize on that insight—not next quarter, but next week.
Without that operational agility, AI-driven intelligence remains trapped in a dashboard.
Putting It Into Practice: A Modern Healthcare GTM Strategy
From the Fullcast perspective, we see leading healthcare and life sciences companies moving from a static to a dynamic GTM model. Here’s how the synergy between AI and RevOps plays out in practice.
1. From Geographic Territories to Data-Driven Coverage Models
The Old Way: Carving up territories based on state lines or drive times.
The New Way: AI algorithms analyze claims data, procedural volumes, and technology adoption rates to identify high-value “micro-markets.” A RevOps platform then uses this intelligence to design balanced and equitable territories. You can create specialized teams and assign them to accounts based on potential, not proximity. This ensures your most valuable resources are focused on your most valuable opportunities.
2. From Manual Routing to Precision Opportunity Assignment
The Old Way: A lead comes in and is routed based on a simple round-robin or by an overworked sales manager.
The New Way: AI scores an incoming opportunity based on dozens of variables—the provider’s specialty, existing technology stack, patient demographics. Our RevOps platform, Fullcast, then executes complex routing rules in real-time.
This precision is critical in an industry where 81% of buyers want to connect with sales reps early in the buying process. The opportunity is instantly routed to the correct specialist, shortening sales cycles and improving the customer experience.
3. From Annual Planning to Agile GTM Adaptation
The Old Way: GTM planning is a painful, once-a-year event based on last year’s performance.
The New Way: The GTM plan is a living, breathing entity. When AI detects a market shift—such as a new competitor gaining traction or a change in reimbursement policies affecting a key segment—RevOps leaders can use a platform like Fullcast to model the impact of potential changes. This agility is essential, as organizations with aligned RevOps functions achieve 34% faster revenue growth than their peers.
They can simulate new territory alignments, team structures, or compensation plans before deploying them, ensuring the organization can pivot with confidence and speed.
The Future is Operationally Excellent
In the new era of healthcare, the winning organizations will be those that master their go-to-market operations. Success demands an intelligent, agile, and data-driven commercial engine.
AI provides the map, showing you the fastest route to revenue. But RevOps builds the roads, traffic signals, and highway infrastructure that allow your entire GTM team to travel at speed. The future of healthcare isn’t just about better medicine; it’s about building a better business. And the pulse of that business is a GTM engine powered by the potent combination of artificial intelligence and operational rigor.
